Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67,604,359
-
Total 13F shares
-
1,658,886
-
Share change
-
-6,524,735
-
Total reported value
-
$3,911,007
-
Price per share
-
$2.36
-
Number of holders
-
29
-
Value change
-
-$15,365,244
-
Number of buys
-
24
-
Number of sells
-
4
Institutional Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q4 2017
As of 31 Dec 2017,
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,658,886 shares.
The largest 10 holders included
FRONTIER CAPITAL MANAGEMENT CO LLC, WASATCH ADVISORS INC, TPG Group Holdings (SBS) Advisors, Inc., Alyeska Investment Group, L.P., Vanguard Group Inc, JACOBS LEVY EQUITY MANAGEMENT, INC, BlackRock Inc., UBS Group AG, Ausdal Financial Partners, Inc., and WEDBUSH SECURITIES INC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.